Inventor
ZHANG GUOLIANG
CN29 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG GUOLIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEIGENE LTD
15 patentsUS9670203B2Jun 6, 2017
Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors
BEIGENE LTD4 citations84
US10864203B2Dec 15, 2020
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
BEIGENE LTD10 citations83
US10647714B2May 12, 2020
5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases
BEIGENE LTD2 citations73
US10562899B2Feb 18, 2020
Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors
BEIGENE LTD1 citations73
US10351559B2Jul 16, 2019
Maleate salts of a B-RAF kinase inhibitor, crystalline forms, methods of preparation, and uses therefore
BEIGENE LTD2 citations73
US10280163B2May 7, 2019
5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases
BEIGENE LTD5 citations73
US10208038B2Feb 19, 2019
Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors
BEIGENE LTD2 citations73
US9920055B2Mar 20, 2018
Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors
BEIGENE LTD3 citations73
US10576087B2Mar 3, 2020
Fused tricyclic compounds as Raf kinase inhibitors
BEIGENE LTD2 citations72
US9895376B2Feb 20, 2018
Fused tricyclic compounds as Raf kinase inhibitors
BEIGENE LTD3 citations72
US11534431B2Dec 27, 2022
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
BEIGENE LTD1 citations62
US10882856B2Jan 5, 2021
5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases
BEIGENE LTD1 citations62
US12582604B2Mar 24, 2026
Stable solid dispersion of a B-RAF kinase dimer inhibitor, methods of preparation, and uses therefor
BEIGENE LTD0 citations56
US11472811B2Oct 18, 2022
Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonist
BEIGENE LTD0 citations52
US12281119B2Apr 22, 2025
Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist
BEIGENE LTD0 citations48